Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Spitznas M . Pathogenesis of central serous retinopathy: a new working hypothesis. Graefe's Arch Clin Exp Ophthalmol 1986; 224: 321–324.
Pikkel J, Beiran I, Ophir A, Miller B . Acetazolamide for central serous retinopathy. Ophthalmology 2002; 109 (9): 1723–1725.
Tatham A, Macfarlane A . The use of propanolol to treat central serous chorioretinopathy: an evaluation by serial OCT. J Ocul Pharmacol Ther 2006; 22 (2): 145–149.
Nielsen JS, Weinreb RN, Yannuzzi L, Jampol LM . Mifepristone treatment of chronic central serous chorioretinopathy. Retina 2007; 27 (1): 119–122.
Kanski JJ . Central serous retinopathy. In: Clinical Ophthalmology: A Systematic Approach, 5th edn. Butterworth-Heinemann: London, 2003, pp 421–423.
Author information
Authors and Affiliations
Corresponding author
Additional information
The computer program designed by this patient, ‘CSR utility’, is currently freely available to clinicians and patients at http://www.gpsu.co.uk/csru/
An example of how to use the program is available to download from http://www.gpsu.co.uk/csru/mmcsr.html
Rights and permissions
About this article
Cite this article
Turnbull, A., Abu-Ain, M., Lash, S. et al. Novel software to self-monitor central serous retinopathy. Eye 24, 179 (2010). https://doi.org/10.1038/eye.2009.40
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2009.40